Biotech News
-
XPhyto Announces Business Strategy and Milestones For 2021 Innovation to Impact
January 18, 2021 (Source) — Commercialization of rapid COVID-19 PCR test Clinical validation of transdermal and sublingual drug…
-
XPhyto Therapeutics Closes Fully Subscribed Private Placement
January 15, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) (“XPhyto” or the “Company”), has completed its previously announced and fully…
-
DIAGNOS Announces Partnership in Saudi Arabia with Magrabi Hospitals and Centers to Screen Diabetic Patients
January 14, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK), (OTCQB: DGNOF), a leader in…
-
Ichor Blood Services and StageZero Life Sciences Launch Virtual COVID-19 PCR Testing Program for Canadians Returning Home from the US
January 13, 2021 (Source) — Testing program allows Canadians to take a lab quality COVID-19 test kit with them…
-
Valeo Pharma Highlights MDBriefCase Newsletter Comparing Hesperidin and Vitamin C for COVID-19
January 12, 2021 (Source) — Growing body of research suggests Hesperidin may interfere with SARS-CoV-2 infection process Hesperidin…
-
StageZero Life Sciences to Present at the SNN Network Canada Virtual Event on Thursday, January 7, 2021
January 6, 2021 (Source) — StageZero Life Sciences (TSX:SZLS), a company dedicated to the early detection of cancer…
-
XPhyto Therapeutics Announces Private Placement
January 5, 2021 (Source) — XPhyto Therapeutics Corp. (CSE:XPHY) (OTC:XPHYF) (FSE:4XT) (“XPhyto” or the “Company”), is pleased to announce…
-
DIAGNOS Provides Market Activity Update
January 5, 2021 (Source) — Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader…
-
Sixth Wave Issues Common Shares to Pay Debenture Interest
January 4, 2021 (Source) — Sixth Wave Innovations Inc. (CSE: SIXW) (OTCQB: ATURF) (FSE: AHUH) (“Sixth Wave” or the “Company”) has issued…
-
Hemostemix Announces Grant of Stock Options
January 4, 2021 (Source) — Hemostemix Inc. (TSXV: HEM) (OTC: HMTXF) (“Hemostemix” or the “Company”) announces that, in…
